Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NonValvular Atrial Fibrillation”

Showing 20 of 0 results

Not applicableStudy completedNCT01721837
What this trial is testing

Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 4,340
Not applicableStudy completedNCT02975453
What this trial is testing

Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban

Who this might be right for
Atrial Fibrillation
Bayer 1,481
Large-scale testing (Phase 3)Study completedNCT00412984
What this trial is testing

Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

Who this might be right for
Atrial FibrillationAtrial Flutter
Bristol-Myers Squibb 20,976
Not applicableStudy completedNCT02591732
What this trial is testing

A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 52,178
Not applicableStudy completedNCT04509193
What this trial is testing

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

Who this might be right for
Atrial Fibrillation
Bayer 116,049
Testing effectiveness (Phase 2)Study completedNCT01229254
What this trial is testing

Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter

Who this might be right for
Atrial FibrillationAtrial Flutter
Portola Pharmaceuticals 189
Not applicableStudy completedNCT02007655
What this trial is testing

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

Who this might be right for
NonValvular Atrial Fibrillation
Bristol-Myers Squibb 6,372
Not applicableStudy completedNCT04494347
What this trial is testing

Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)

Who this might be right for
Nonvalvular Atrial FibrillationSevere Degenerative Mitral Regurgitation
Mayo Clinic 25
Testing effectiveness (Phase 2)UnknownNCT02937025
What this trial is testing

Study of Safety and Efficacy of a Left Atrial Appendage Occulder

Who this might be right for
Non-valvular Atrial FibrillationStroke
Ya-Wei Xu 154
Not applicableStudy completedNCT02944019
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 13,980
Not applicableUnknownNCT02181374
What this trial is testing

The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation.

Who this might be right for
Ischemic Stroke
Xijing Hospital 1,000
Not applicableStudy completedNCT05342220
What this trial is testing

Effect of Ischemic Preconditioning on Atrial Fibrillation After Electrocardioversion

Who this might be right for
Atrial Fibrillation
St. Josefs-Hospital Wiesbaden GmbH 240
Not applicableStudy completedNCT04586972
What this trial is testing

Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;

Who this might be right for
Nonvalvular Atrial Fibrillation
Gérond'if 977
Not applicableStudy completedNCT03572972
What this trial is testing

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

Who this might be right for
Atrial Fibrillation
Pfizer 64,684
Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Who this might be right for
Atrial Fibrillation
Bayer 1,504
Not applicableStudy completedNCT02769078
What this trial is testing

Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 14,201
Not applicableStudy completedNCT03134911
What this trial is testing

Health-related Quality of Life in Patients on Anticoagulants

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 535
Not applicableStudy completedNCT03087487
What this trial is testing

Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation

Who this might be right for
Non-Valvular Atrial Fibrillation
Bristol-Myers Squibb 466,991
Not applicableStudy completedNCT02447341
What this trial is testing

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Who this might be right for
Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke
Bristol-Myers Squibb 987
Not applicableStudy completedNCT02919982
What this trial is testing

Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
Baim Institute for Clinical Research 817
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation